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EFFECTS OF GENETIC VARIABILITY ON FRACTURE HEALING: A 
TEMPORAL STUDY OF GENE EXPRESSION AND CALLUS PHENOTYPE 
HEATHER E. MATHENY 
ABSTRACT 
 Bones have a large intrinsic capacity for repair and regeneration following 
an injury, however, an estimated 5-10% of nearly 8 million fractures that occur 
every year in the United States lead to nonunions.  The process of bone 
regeneration is a complex trait that brings together different complements of 
molecular and cellular interactions to carry out its necessary mechanical 
functions.  These interactions may be attributable to the effects of genetic 
variations that contribute to differences in bone morphology and fracture healing.  
This study was undertaken to determine how genetic variability that controls 
phenotypic qualities of bone affect rates and patterns of fracture healing.  Three 
inbred strains of mice (A/J (AJ), C57BL/6J (B6), and C3H/HeJ (C3)) with known 
structural and biomechanical differences resulting from fetal bone development 
were examined.  Transverse fractures were generated in the femur and healing 
traits were evaluated using quantitative real-time polymerase chain reaction 
(qRT-PCR), micro-computed tomography (µCT), biomechanical torsional testing, 
and cartilage contrast-enhanced micro-computed tomography (CECT).  The 
temporal analysis of gene expression revealed that B6 had the longest duration 
of chondrocyte maturation and the greatest relative expression of osteogenic 
genes relative to either C3 or AJ.  While AJ and C3 exhibited similar patterns of 
  vii
chondrogenesis, AJ initiated osteogenesis earlier than C3.  These results 
suggest that compared to either AJ or B6, the C3 strain exhibited the least 
temporal coordination between the chondrogenic and osteogenic stages.  
Consistent with the relative patterns of RNA expression, µCT evaluations at day 
21 post fracture showed that B6 had higher callus mineralization than AJ and C3.  
µCT, cartilage CECT, and biomechanical testing revealed less tissue 
mineralization and more cartilage near the fracture gap, which indicated a less 
developed bony bridge in C3 calluses at day 21 post fracture.  The lack of large 
amounts of cartilage in calluses of all strains by day 21 indicated that all strains 
had initiated osteogenesis by this time.  Taken together, these results showed 
that mice with different genetic backgrounds express different patterns of 
mobilization and renewal of skeletal stem cells with differing temporal 
progressions of chondrogenic and osteogenic differentiation.  These data further 
show that these variations affect the phenotypic properties of fracture calluses 
during the process of fracture healing. 
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 1 
INTRODUCTION 
 
The skeletal organs of vertebrates consist of several tissue types: 
cartilage, bone, bone marrow, and blood vessels.  Through many embryonic 
phases of cell condensation, differentiation, and morphogenesis, the skeletal 
tissue structure is established.  Conserved signaling pathway interactions 
between bone, cartilage, marrow, and vasculature create a unique 
microenvironment that coordinates skeletogenesis, or bone formation (Colnot, 
2005; Karsenty, 2008).  Depending on the type of bone, development can occur 
through one of two separate methods, intramembranous ossification or 
endochondral ossification.  Flat bones such as those in the cranial skeleton 
develop through intramembranous ossification, which develop directly from 
mesenchymal precursors (Bronner, Farach-Carson, & Roach, 2010).  In this way, 
condensed mesenchymal stem cells (MSC) are invaded by vasculature leading 
to their differentiation into mature osteoblasts.  Mature osteoblasts secrete 
osteoid, an unmineralized bone matrix, which is the foundation of that specific 
bone.  Long bones of the appendicular skeleton and vertebrae bodies of the axial 
skeleton, on the other hand, develop through endochondral ossification.  The 
process of endochondral ossification also occurs through the condensation of 
mesenchymal cells, but form a cartilage anlage on which subsequent bone 
tissues are modeled (DeLise, Fischer, & Tuan, 2000).  Within specified areas of 
these tissues, chondrocytes undergo a programmed differentiation in which they 
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become hypertrophied and express differentiated functions that allow these to 
mineralize and promote vasculature invasion.  Vascular invasion brings about the 
programmed death of chondrocytes and the recruitment of other cells such as 
osteoclasts and osteoblasts that leads to the replacement of the original cartilage 
with bone (Gerber et al., 1999).  
Although we generally consider development as events taking place in the 
embryo through birth, data suggest that similar molecular and cellular 
mechanisms coordinate prenatal developmental processes that facilitate 
postnatal skeletal growth and repair (Ferguson, Alpern, Miclau, & Helms, 1999; 
Vortkamp et al., 1998).  Specific skeletogenic processes that occur during 
embryogenesis persist for the duration of the life of the vertebrate during a 
continuous process of remodeling and, in the event of an injury or defect, are 
used to reestablish injured bones during a process of fracture repair.  In contrast 
to soft tissues in which a scar of connective tissue is formed through the healing 
process, bones produce new bone through the healing process (Einhorn, 1998).  
Accordingly, fracture repair can be defined as a true regenerative process. 
 
Stages of Fracture Healing 
Bone has a large capacity to undergo repair and regeneration to its 
original condition following an injury (Einhorn, 1998).  A complex coordination of 
inflammatory cells, cytokines, and growth factors stimulate the cellular and 
molecular events that occur during fracture healing (Ai-Aql, Alagl, Graves, 
Gerstenfeld, & Einhorn, 2008; Barnes, Kostenuik, Gerstenfeld, & Einhorn, 1999; 
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Stone, 1997).  The site of the injury creates the environment to establish and 
stimulate the regeneration of damaged tissues.  The orchestration of events to 
repair the defect site occurs between the surrounding tissues and newly forming 
tissue to form a bridging callus over the fractured bone (Einhorn, 1998).  The 
bridging callus is made of a cartilaginous soft callus and a bony hard external 
callus (Gerstenfeld et al., 2006). 
The periosteal reaction, responsible for the callus formation, is 
characterized as a process where the cambial layer of the periosteum thickens 
by proliferation (Figure 1).  At the central region, two crescent shaped bodies of 
cartilage are formed around the fracture line, which taper proximally and distally 
away from the fracture (Gerstenfeld et al., 2003).  This response is responsible 
for producing the cartilage surrounding the fracture line that will provide the 
eventual support over which the formation of a hard callus shell of woven bone 
will form.  At the same time, a set of wedge- shaped areas of intramembranous 
 
 
Figure 1.  Diagrammatic representation of fracture repair.  A sagittal cross-section of tissue 
development illustrating the relative locations of endochondral bone formation and 
intramembranous bone (Figure modeled after Gerstenfeld et al., 2003). 
Intramembranous Bone 
Cortical Bone 
   
  
  
Marrow Space 
  
  
Endochondral Bone (cartilage) 
Fracture 
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bone formation begins at the proximal and distal edges of the periosteal reaction, 
adjacent to the central areas where cartilage is forming, and taper towards both 
the region of the fracture and away from the fracture (Gerstenfeld et al., 2003).  
Thus, the mechanism of bone repair utilizes both endochondral and 
intramembranous bone formation processes.  This is referred to as secondary or 
indirect healing (Jahagirdar & Scammell, 2009; Marsell & Einhorn, 2011).  The 
tissue interactions where codependent development of bone and cartilage takes 
place are apparent upon histological examination of the regenerative regions of 
the fractured bone (Figure 2).  The events that occur during fracture healing are 
commonly described as four overlapping stages based on these histological 
events that take place (Gerstenfeld, Cullinane, Barnes, Graves, & Einhorn, 
2003). 
 
Stage 1: Inflammation 
 
Immediately after a bone fracture occurs, a hematoma begins to form and 
the inflammatory response is initiated.  The non-specific inflammatory response 
is activated by damage to the fractured bone and surrounding tissue (Marsell & 
Einhorn, 2011).  Blood from the periphery and intramedullary canal surrounding 
the fracture provide the framework of a fibrin clot and emigration of leukocytes 
and other blood cells in the focus of injury (Einhorn, 1998).  The inflammatory 
cells remove necrotic tissue created by the disruption of nerves and blood 
vessels, and hypoxic region, as well as prevent infection (Einhorn, 1998; 
Gerstenfeld et al., 2003).  These cells release cytokines and various growth  
 5 
                  
 
Figure 2. Histological stages of fracture healing.  The stages of fracture healing can be 
described based on the histological presentation of events.  A. Section for the initial injury 
involving inflammation, the marrow response, the formation of a hematoma, and the MSC 
recruitment to the site of injury.  B. Endochondral formation, involving cartilage formation and the 
periosteal response.  Arrows indicate vascular in growth.  C.  Intramembranous formation 
involving bone cell recruitment, chondrocyte apoptosis, matrix degradation, osteoclast 
recruitment, and neovascularization.  Arrows indicate neovascular in growth.  Insert is a 400x 
magnification of an osteoclast resorbing a region of calcified cartilage.  D. Secondary bone 
formation involving marrow establishment, bone remodeling by osteoclasts, and osteoblast 
recruitment.  Insert is a 400x magnification of an osteoclast resorbing a region of 
intramembranous bone  (Figure modified from Gerstenfeld et al., 2003). 
 
 
factors, which form the hematoma and eventually granulation tissue with the 
development of new capillaries (Jahagirdar & Scammell, 2009).  As the 
granulation becomes more fibrous with connective tissue, it reduces strain on the 
forming tissue and serves as the scaffold between the broken ends of bone 
where cartilage later forms (Rahn, 2002).  The various mediators released by the 
cells and platelets stimulate MSCs to undergo differentiation into chondrocytes 
(Bais et al., 2009).  The upregulation of key mediators, such as Hypoxia-induced 
factor-α (HIF-α), Vascular Endothelial Growth Factor (VEGF), and Bone 
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Morphogenetic Proteins (BMP) trigger neoangiogenesis and recruitment of MSCs 
(Bostrom et al., 1995; Marsell & Einhorn 2011; Towler, 2008). 
 
Stage 2: Soft Callus Formation 
Adjacent to the fractured bone resides four regions that are associated 
with the healing process (Marsell & Einhorn, 2011).  They are the medullary 
canal, the fracture gap between the cortices, the periosteum, and the 
surrounding soft tissue.  The former two contribute to the formation of a soft 
fibrocartilage callus that is then ossified to bone via endochondral ossification 
(Bronner et al., 2010).  This process is presumably achieved by recapitulating 
fetal skeletogenesis (Ferguson et al., 1999).  The development of two cell 
lineages (chondrocytes and fibroblasts) from multipotent MSCs provides the 
basis of endochondral ossification (Bais et al., 2009).  Endochondral ossification, 
as briefly noted earlier, is initiated with the recruitment, proliferation, and 
condensation of mesenchymal stem cells into a shape that fills in the fracture 
gap.  This cartilage framework provides a semi-rigid, soft callus (Gerstenfeld et 
al., 2006).  MSCs are recruited from the periosteum, bone marrow, and adjacent 
soft tissues (Colnot, Huang, & Helms, 2006; Rumi, Deol, Singapuri, & Pellegrini, 
2005).  MSCs differentiate into chondrocytes that synthesize a cartilage matrix 
over the fibrous granulation tissue formed in the inflammation stage (Marsell & 
Einhorn, 2011).  The two crescent shaped regions of cartilage described earlier 
continue to grow inwards toward the fracture gap until they meet and form a 
fibrocartilage scaffold over the defect (Gerstenfeld et al., 2006).  Chondrocytes 
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then undergo a period of hypertrophic growth and initiate the secretion of VEGF, 
which plays a large role in angiogenesis (Carlevaro, Cermelli, Cancedda, & 
Descalzi Cancedda, 2000; Keramaris, Calori, Nikolaou, Schemitsch, & 
Giannoudis, 2008).  Angiogenesis is important for the high metabolic activity in 
bone regeneration because the new blood vessels allow for the delivery of 
necessary nutrients and oxygen (Towler, 2008). 
The newly formed extracellular matrix (ECM) of hyaline cartilage and other 
fibrous proteins is then calcified (Schindeler, McDonald, Bokko, & Little, 2008).  
As the chondrocytes hypertrophy, they no longer produce collagen and other 
glycosylated proteins and start producing alkaline phosphatase, an enzyme 
required for hydroxyapatite deposition (de Crombrugghe et al., 2000; Kirsch, 
Nah, Shapiro, & Pacifici, 1997).  The matrix is then calcified and osteoprogenitor 
cells differentiate into osteoblasts, which secrete osteoid over the scaffold of 
calcified matrix in a process that forms trabecular bone (Kirsch et al., 1997).  
Calcification takes place from the proximal and distal ends, towards the center of 
the fracture (Gerstenfeld et al., 2006).  Concurrently, chondrocytes undergo 
apoptosis due to the hypoxic conditions created by calcification, cartilage 
matrices are degraded by metalloproteinases, and vasculature invades the new 
mature calcified tissue (de Crombrugghe et al., 2000).  The process of 
mineralization and degradation of cartilage matrices is also suggested to be a 
recapitulation of embryonic skeletal formation (Ferguson et al., 1999).  
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Stage 3: Hard Callus Formation 
During the stage of hard callus formation, through the process of 
intramembranous ossification, or primary bone formation, bone develops without 
a cartilaginous template and is initiated by osteoprogenitor cells and MSCs 
(Gerstenfeld et al., 2003).  The subperiosteal region and bone marrow are likely 
to provide MSCs necessary to create the hard callus (Colnot et al., 2006; Phillips, 
2005).  The source of osteoprogenitor cells has not been well established, but 
they may originate from the circulation or surrounding tissues (Eghbali-
Fatourechi et al., 2005; Rumi et al., 2005).  Notably, intramembranous bone can 
form in regions where fractures have greater stability, though most bones heal 
using both models of bone formation due to the unstable nature of fracture 
fragments (Yu, Bahney, Hu, Marcucio, & Miclau,, 2012).  Together, the hard 
callus and soft callus form what is known as the bridging callus (Marsell & 
Einhorn, 2011).  The new layer of woven bone made of various proteins and 
mineralized ECM is synthesized by osteoblasts (mature osteoprogenitor cells).   
 
Stage 4: Bone Remodeling  
In the final stage of bone regeneration, woven bone formed by 
endochondral and intramembranous bone formation are both replaced by 
lamellar bone, or secondary bone, and finally remodeled into the native cortical 
and/or trabecular bone (Gerstenfeld et al., 2003).  This stage is associated with 
the balance of bone resorption and bone formation (Sims & Gooi, 2008).  The 
calcified cartilage is replaced with lamellar bone by the recruitment of osteoclasts 
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and osteoblasts through the signaling pathway involving Receptor activator of 
nuclear factor kappa-β (RANK), Receptor activator of nuclear factor kappa-β 
ligand (RANKL), and osteoprotegerin (OPG) molecules (Sims & Gooi, 2008).  
The osteoclast is a multinucleated cell that is derived from macrophages and 
mature monocytes.  Osteoclasts pump acid and proteinases to degrade the 
surface of the bone that is to be resorbed (Sims & Gooi, 2008).  Osteoblasts then 
make new bone over the eroded surface created by osteoclasts (Schindeler et 
al., 2008).  The final outcome of the fracture repair and bone regeneration 
process is bone that has the original architecture and biomechanical strength 
prior to the injury (Marsell & Einhorn, 2011). 
 
Risk Factors for Nonunion Fractures 
Bone fractures in most people heal without any complication.  Despite the 
bone’s intrinsic capacity for repair and regeneration following an injury, there are 
instances in which a delayed union or nonunion result in an impaired healing 
process (Cameron et al., 2013).  A delayed union is a fracture that heals in a time 
longer than is expected for that particular bone (Jahagirdar & Scammell, 2009).  
When the two ends of a bone fail to join across the fracture gap in a reasonable 
elapse of time, this is referred to as a nonunion (Cameron et al., 2013).  This 
occurs when there is a complete cessation of the repair process.  There is 
discrepancy in the literature, however, about when to define a fracture as a 
nonunion because it is difficult to set a fixed amount of time to the healing 
process (Marsh, 1998; Russell, Taylor, & Lavelle, 1991).  Moreover, even with 
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the advanced therapies and surgical procedures that exist for treating fractures, 
an estimated 5-10% of nearly 8 million fractures that occur every year in the 
United States lead to nonunions (Praemer, Furner, & Rice, 1999).  The costs 
associated with delayed and nonunion fractures and related complications for 
adults alone are estimated to reach over $54 billion in the US by 2020 
(Englander, Hodson, & Terregrossa, 1996). 
There are considerable risk factors that contribute to a nonunion (Table 1).  
In order for bones to heal, the two ends of the fracture must be aligned properly 
and immobilized.  If the bone is not aligned properly the optimal size callus that 
promotes adequate healing does not form (Heppenstall, Brighton, Esterhai, & 
Muller, 1984; Jagodzinski & Krettek, 2007).  This is because a certain amount of 
strain on the bone is required to stimulate the cell responses in the healing 
cascade (Jagodzinski and Krettek, 2007).  Mechanical stability is also important 
for vascular growth in the injured region, where micromotion between the 
fragment pieces has been shown to produce greater vascularization compared to 
greater motion between the fragment pieces (Claes, Eckert-Hübner, & Augat, 
2002; Lienau et al., 2005).  Thus, micromotion allows for adequate blood and 
nutrient flow that are critical for repair due to its ability to carry the necessary 
cells as mentioned earlier, as well as other contributory factors such as the 
oxygen tension required for osteoblast differentiation (Sheehy, Buckley, & Kelly, 
2012).  Studies have also shown that angiogenesis promotes bone healing and 
osteogenesis, but angiogenesis alone is not sufficient (Karamaris et al., 2008; 
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Morgan et al., 2012).  Other factors that can lead to decreased blood flow to the 
injury are inflammation and infection, vascular disorders associated with diabetes 
and obesity, and constriction of blood vessels caused by nicotine in cigarettes 
(Heppenstall et al., 1984; Loomer & Kokan, 1976; Schmitz et al., 1999).  
 
Table 1.  Factors that affect fracture healing.  Common factors that affect bone healing.  Local 
factors are associated with the bone and fracture.  Systemic factors are associated with the entire 
body (Table modified from Cameron et al., 2013). 
 
Interestingly, commonly prescribed medication can also inhibit bone 
healing.  The use of non-steroidal anti-inflammatory drugs (NSAIDS), which are 
commonly used to decrease pain and swelling, can impair healing (Gaston & 
Simpson, 2007).  NSAIDs are known to inhibit cyclooxygenase (COX) that leads 
to the inhibition of prostaglandin synthesis in the inflammatory pathway 
(Cashman, 1996).  A study of mice that were administered rofecoxib, an NSAID, 
showed reduced blood flow in the area of the fracture gap, which appeared to 
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exhibit inhibition of fracture repair through the impaired process of angiogenesis 
(Claes et al., 2002).  Also, the long-term use of corticosteroids as an 
immunosuppressant and anti-inflammatory agent has been shown to inhibit 
fracture healing through inhibition of Insulin-like Growth Factor-1 and 
Transforming Growth Factor-β production.  The production of these, and other, 
growth factors are required to stimulate bone formation (Baylink, Finkelman, & 
Mohan, 1993).  This inhibition was shown in another study of mice where the 
experimental group, which was administered prednisone, showed an 
approximately 60% higher rate of nonunion compared to the control group 
(Waters et al., 2000). 
The morphology of the fracture is also a risk factor for nonunions.  There 
are certain fracture patterns that are known to have more complications, such as 
oblique, spiral, and comminuted (Figure 3) (Gaston & Simpson, 2007; 
Heppenstall et al., 1984).  The size of the fracture gap can also impact the 
chances of healing, such that when it becomes too large, the fracture will not 
completely heal (Marsh, 1998).  This is termed a critical size defect.  In contrast 
to non-critical size defects, which heal through a natural tendency for a cellular 
and molecular response, critical size defects will not (Brinker, 2003).  The size of 
the defect has been shown to influence revascularization and cell differentiation 
(Claes et al., 2002).  
 13 
 
Figure 3.  Fracture patterns.  Common fracture patterns, typical causes associated 
with the type of fracture, and mechanism of action (Figure modified from Bates & 
Ramachandran, 2007). 
 
 
Even though many factors have been recognized that affect bone healing, 
such as growth factors involved in the molecular cascades of bone healing, 
mechanical stability of the fracture, size of the fracture gap, and use of various 
pharmaceuticals as described above, different patterns of healing are seen 
among fracture cases within the clinical setting (Baylink et al., 1993; Rosen & 
Thies, 1995).  This is even true among the 95% of fractures that heal without 
problems (Praemer et al., 1999).  For example, recognized differences in healing 
patterns may include the time frame of the repair process and differences in 
callus formation (Jepsen et al., 2008).  Furthermore, there are reports of 
spontaneous healing of critical size defects in femoral fractures of patients 
awaiting surgery for revision (Hinsche, Giannoudis, Matthews, & Smith, 2003), as 
well as enhanced healing in mice with a deficiency in 5-lipoxygenase (a gene 
repressor in fracture healing) (Manigrasso & O’Connor, 2010).  Also, delayed 
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union or nonunion is reported in 5-10% of fractures in patients with comparable 
risk factors (Praemer et al., 1999). 
 
Genetic Variability 
Considering that bone healing is a complex genetic trait that is still not 
completely understood, as with many biological processes, and the recognized 
diversity among bone repair, the ultimate fate of the process could be due to the 
genetic variations in individuals.  Thus, a fundamental understanding in the 
context of how polygenic networks affect cellular and molecular pathways during 
bone regeneration is central to improving our understanding of fracture healing.  
Although there is a limited understanding of the potential influence of genetic 
variability in fracture healing between individuals with unremarkable fracture 
healing, studies point out the possibility of genetic influence in cases of nonunion 
(Dimitriou, Carr, West, Markham, & Giannoudis, 2011). 
The significance of polygenic networks as a determinant for nonunions 
and compromised fracture healing has not been well established, but additional 
studies advocate a link between gene variations and nonunions (Brinker, 2003; 
Dimitriou et al., 2011).  For example, Dimitriou, Carr, and West (2011) examined 
the variation of a single nucleotide in 4 genes (BMP-2, BMP-7, NOGGIN and 
SMAD6) of the BMP pathway.  They utilized the single nucleotide polymorphisms 
(SNPs) of these genes, which are known to be involved in bone healing, to 
assess the genetic variability of bone healing responses.  Since the BMP 
pathway is known to contain important osteoinductive molecules (Nakase & 
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Yoshikawa, 2006), the diversity of the genetic profiles of genes in this pathway 
may follow the differences observed in fracture repair.  The use of SNPs to 
investigate variations in specific genes can then be applied to determine the 
susceptibility or predisposition of an individual to inherit a certain 
pathophysiology, such as impaired fracture healing (Hirschhorn & Daly, 2005).  
While there are a few considerations that associate the genetic profile with 
fracture healing, there are studies that suggest that bone mineral density (BMD) 
may also correlate with the genetic profiles (Beamer, Donahue, Rosen, & 
Baylink, 1996; Heaney et al., 2000).  Measurements of bone composition, such 
as BMD, contribute to our understanding of differences in bone traits among 
different genetic backgrounds.  By analyzing messenger ribonucleic acid (mRNA) 
that relate to BMD, variations in the level of mRNA expressions have been 
identified and associated with differences in BMD (Gu et al., 2002).  Furthermore, 
inbred strains of mice attain distinct sets of adult bone traits as a result of genetic 
regulation of bone surface remodeling, pattern of growth, and mineral 
accumulation throughout long bone development (Price, Herman, Lufkin, 
Goldman, & Jepsen, 2005).  Despite this progress, there is still little 
understanding about the inheritance of fracture healing and its relationship to 
bone density.  However, if traits such as BMD are a regulated part of bone 
growth, and since it is very likely that adult bone healing is a recapitulation of 
bone formation in the embryo, then these variations in developmental genes 
should be repeated during bone healing.  This could be significant given the fact 
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that kindred and twin studies estimate that about 70% of the variability in human 
adult bone density is related to polygenic networks (Beamer et al., 1996).  
In addition to studies that focus on bone traits such as BMD, there are 
experiments that propose the potential of hereditary genes with bone 
regeneration.  Several in vivo studies have established the notion that bone 
regeneration significantly varies among inbred strains of mice with different 
genetic backgrounds (Jepsen et al., 2008; Manigrasso & O’Connor, 2008).  
There is also evidence that mice with different genetic backgrounds exhibit 
different temporal profiles of each of the stages in the fracture healing cascade 
(Jepsen et al., 2007).  Thus, a fundamental understanding in the context of how 
polygenic networks affect cellular and molecular pathways during bone 
regeneration is key to improving our understanding of fracture healing.  
Further investigation of these indispensable clues is essential in 
elucidating the genetic complexity of bone repair and regeneration.  The clinical 
significance of understanding the relevance of genetic variability as it pertains to 
fracture healing could, for example, allow a better understanding of the etiology 
of diseases or an individual’s susceptibility to disease.  Currently, we know 
genetic variations exist between individuals, but we do not understand the 
possible significance and role of polygenic diversity.  Accordingly, the genetic 
diversity of genes expressed during bone repair may be the underlying cause of 
the variability observed during this process, whether it is an enhanced or 
impaired heritability for fracture healing. 
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These studies should begin to elucidate how underlying genetic variability 
affects gene expression and callus phenotype during fracture healing.  We hope 
to use this understanding of varying genetic backgrounds to allow us to begin to 
surmise how the constituent parts merge together and to identify the fundamental 
components that regulate this complex trait. 
 
Objectives 
Fracture healing is considered a complex trait, meaning that many various 
and characteristic phenotypic qualities contribute to this process due to their 
interactions with genetic and environmental components.  These phenotypic 
properties include characteristics such as the matrix and mineral composition, 
and the architecture of the callus.  The composition of these characteristics is in 
turn the product of the polygenic network genes and the several cell types 
involved in the repair process.   
The objective of the present study was to investigate fracture healing 
under differing genetic backgrounds.  Since it is largely established that bone 
healing is a recapitulation of fetal bone development, employing the same 
molecular mechanisms as used during development, we hypothesized that these 
same developmental mechanisms would lead to variations in structural and 
material properties throughout the temporal duration of fracture healing and 
callus formation, and would also lead to different rates of healing.  Specifically,  
1. To examine genetic variability, our approach used three inbred strains 
of mice that exhibit variable bone properties that represented the 
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genetic variability observed in human populations.  Inbred mice have 
been strategically used for experimentally controlling genetic variability 
because they allow for the reproduction of genetically identical mice.  
Moreover, each of these strains of inbred mice was genetically 
different from the rest, ensuring consistent variation. 
2. To identify differential gene expressions that contribute to fracture 
healing, we isolated total RNAs (TRNA) from fracture calluses from 
each of the three inbred stains of mice at multiple timepoints after a 
fracture procedure and compared the expression to unfractured bones. 
3. To establish the structural phenotypic relationships among functional 
properties of the fracture callus that contribute to fracture healing, we 
utilized micro-computed tomography, contrast-enhanced micro-
computed tomography, and biomechanical torsional testing.  We used 
micro-computed tomography to generate quantitative measurements 
for morphometric analyses and mineralization of the fracture calluses.  
Since the formation of cartilage is an important stage in fracture 
healing, we used a recently developed contrast agent to view the 
otherwise low x-ray attenuation of cartilage.  The biomechanical traits 
during fracture healing were evaluated due to the results of previous 
studies (Jepsen et al, 2008; Morgan et al., 2009) that suggested a 
relationship between bone rigidity, tissue mineral density, bone mineral 
content, and mineralized volume fraction.  Torsional testing was an 
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effect method to test mechanical properties of fracture healing because 
the load was applied at the proximal and distal ends of the bone, away 
from the location of the mid-diaphyseal fracture used in this study. 
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METHODS 
 
Experimental Design  
All experiments were performed in accordance with the Institutional 
Animal Care and Use Committee (IACUC) approved at Boston University School 
of Medicine, and was consistent with Federal and United States Department of 
Agriculture (USDA) guidelines.  Experimental data was obtained on femora of A/J 
(AJ), C57BL/6J (B6), and C3H/HeJ (C3) inbred strains of mice, which are known 
to exhibit different rates of bone formation (Jepsen et al., 2008).  A total of 78 AJ, 
81 B6, and 78 C3 10-week post birth mice were obtained from Jackson 
Laboratories (Table 2) (Bar Harbor, Maine).  Due to sexual dimorphism in 
skeletal structure and hormonal effects of estrogen on bone regulation, male 
mice were exclusively enrolled in this study to prevent potential confounding 
effects (Sims et al., 2002).  The mice were given three days to acclimate to the 
Boston University School of Medicine Laboratory Animal Sciences Center 
(LASC) before beginning the surgical procedure.  The diet consisted of a 
standard mouse chow (Purina Mills Inc., St. Louis, MO, USA) feed free choice 
and water was available continuously.  The mice were kept on a 12 hour light-
dark cycle.  Each animal was weighed prior to beginning the procedure, with 
weights ranging from 18-28g for AJ, 22-30g for B6, and 22-29g for C3.  The 
weights of all animals were monitored throughout the duration of the study, 
where no animal exhibited a significant (20%) amount of weight loss. 
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Table 2. Sample allocation.  Sample allocation for the experimental analyses conducted during 
this study.  Data indicates number of mice per strain and column criteria: study enrollment, 
reason for exclusion, and final sample size for a given experiment. 
 
 
 
Fracture Procedure  
In order to assess the progression of fracture healing, unilateral, 
transverse fractures were generated in the right femora following a surgical 
procedure.  The surgical procedures were performed at the LASC at Boston 
University School of Medicine.  The LASC facility is accredited by the American 
Association for the Accreditation of Laboratory Animal Care (AAALAC). 
Pre-operatively, mice were anaesthetized with an isoflourane and oxygen 
mix administered by inhalation through a nose cone that covered the entire head 
of the mouse.  The initial administration of isoflourane was maintained at 5%, and 
then reduced to 1-3% following induction for the duration of the procedure.  The 
mice were given 0.1 ml of 0.3 mg/ml buprenorphine (Buprenex®) and 0.05 ml of 
5 mg/kg Enrofloxacin (Baytril®) subcutaneously to relieve post-operative pain 
and prevent bacterial infections, respectively.  The right hind leg was shaved 
using an electric razor and wiped with damp gauze to remove hair from the 
surgical site.  The site was then cleansed with a bovidine-iodine solution 
(Betadine®) followed by 70% ethanol. 
qRT-PCR 
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A small incision was made medial to the right patella and both the patella 
and patellar ligament were moved laterally to expose the condylar surface of the 
femur.  A 25G hypodermic needle was used to create an opening into the 
femoral canal towards the femoral head.  A sterile 25G (0.50 mm) x 3 1/2” spinal 
needle (Exel®) was then threaded through the shaft down to the level of the 
lesser trochanter.  The excess wire was clipped with wire cutters.  The purpose 
of the wire was to stabilize the bone once it was fractured.  The skin at the 
incision site was closed with three simple interrupted, absorbable sutures.  While 
still under anesthesia, mice were placed in a supine position with the femur 
aligned under a fracture device (Figure 4).  A modified guillotine device with a 
blunt blade, or striker, was used to generate a fracture (Marturano et al., 2008).  
The striker was attached to a shaft and weight, which was connected to an 
electromagnetic drop assembly that released when a foot pedal was pressed.  
When released, the shaft traveled downward and produced a three-point bend on 
the bone positioned beneath the striker.  This impact force produced a closed 
transverse femur fracture.  The height of the weight was adjusted for the different 
strains of mice due to varying bone properties.   
The bone was initially assessed for fracture by gentle palpitation of the 
femur.  To confirm the location and quality of the fracture and the position of the 
pin placement, an X-ray was taken in the procedure room with a dental X-ray 
device (Gendex, Inc.) at 60kV for 0.16 seconds using Kodak Ultra Speed DF-50, 
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size 4 film.  All fractures that were not located mid-diaphyseal or comminuted 
were excluded from the study. 
 
Figure 4. Murine fracture device.  Image on the left is a computer rendering of the murine 
fracture device with labeled components.  Image on the right is the actual fracture device, with the 
foot pedal labeled “a.”  (Figure taken from Marturano et al., 2008). 
 
 
Post-Operative Treatment 
 Mice were monitored until they regained consciousness from anesthesia 
and were ambulatory.  For 2 days post procedure mice were given a daily 
injection of 0.5- 0.1 ml of 0.3 mg/ml Buprenex® for pain management and were 
monitored for hydration, pain, nerve damage, and pin retraction.  The overall 
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health and recovery of the mice were also examined daily until sacrifice and 
tissue harvest. 
 
Harvesting of Femur 
  
 The fractured femora were harvested on post-operative days 3, 5, 7, 10, 
14, 18, 21, 28, and 35.  Unfractured femurs were harvested on day 0 to use as 
controls.  Mice were euthanized via carbon dioxide inhalation.  The mice were 
moved into a standard cage with a stainless steel euthanasia lid with an attached 
flow meter.  The flow rate was set at 1.3 liters/minute.  CO2 Narcosis was 
followed with cervical dislocation.  Prior to removing the fractured femur, an X-ray 
(Faxitron MX-20 Specimen Radiography System) was taken of each animal at 
30kV for 40 seconds using Kodak BioMax XAR Scientific Imaging Film.   
 To harvest the femur, a skin incision was made over the right femur and 
the skin was dissected away from the underlying tissue.  The femur was removed 
from the animal via disarticulation of the hip and knee.  Muscle and tissue 
overlying the bone was carefully removed to prevent disruption of the fracture 
callus.  The stabilizing pin was removed with Mosquito forceps.  The fracture 
calluses for gene analysis were isolated from the proximal and distal ends of the 
femur and immediately placed into liquid nitrogen.  Fracture calluses for micro-
computed tomography analysis were kept intact with the whole femur and were 
wrapped in 1x phosphate buffered solution- soaked gauze (PBS).  All samples 
were placed into liquid nitrogen immediately after harvest and then stored at -
80°C until further use. 
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RNA isolation  
Each fracture callus sample (AJ n = 57; B6 n = 60; C3 n = 57; post 
fracture days: 0, 3, 5, 7, 10, 14, 18, 21, 28, and 35) was placed in a 2 ml tube 
with 0.75 ml QIAzol Lysis Reagant® then placed into liquid nitrogen for 10 
seconds to snap freeze the sample.  A small 2 mm stainless steel ball was added 
to the tube before being placed in a tissue lyser (QIAgen Tissue Lyser II®) at 30 
Hz for 2-5 minutes until the bone was fully ground.  The homogenate was 
transferred into a new tube containing 1 ml QIAzol Lysis Reagent®, shaken 
lightly, and then allowed to rest for 2 minutes on ice. The tube was vortexed for 
15 seconds with 200 µl chloroform, and then allowed to rest for 2 minutes on ice.  
The mixture was vortexed again for 15 seconds, then centrifuged at 13,200 rpm 
at 4˚C for 15 minutes.  The extracted TRNA was precipitated from the aqueous 
phase with 75 ml isopropanol and centrifuged at 13,200 rpm at 4˚C for 30 
minutes to precipitate the TRNA.  The supernatant was removed and the TRNA 
pellet was washed with 500 µl 75% ethanol and centrifuged at 13,200 rpm at 4˚C 
for 5 minutes.  The RNA pellet was washed again with 500 µl 75% ethanol and 
centrifuged at 13,200 rpm at 4˚C for 5 minutes, dried, and resuspended in 30-40 
µl RNase free water.  The quality of the isolated TRNA was verified with 
electrophoresis on a 1.5% agarose gel with product separation performed at 90V.  
The concentration of TRNA isolated was measured by diluting 1 µl of extracted 
TRNA in 99 µl of 10 mM Tris at pH = 7.5 and transferring the diluted sample into 
a cuvette and placed in a UV/Vis Spectrophotometer (Beckman Coutler DU 350).  
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The resulting absorbance at 260 nm was used to obtain the concentration of 
TRNA from the extraction process.   
 
Reverse Transcription 
Total RNA was reverse transcribed for each femur fracture sample.  Two 
micrograms of total RNA was added to an RNase free microcentrifuge tube and 
diluted with RNase free water for a total volume of 10.4 µl.  A mix of MgCl2 (6.61 
µl), dNTP Mix (6.0 µl), 10x RT buffer (3.0 µl), random hexamers (1.5 µl), RNase 
Inhibitor (0.6 µl), and Taqman Reverse Transcriptase (1.89 µl) was added to 
each tube.  The tubes were placed in a thermal cycler (Eppendorf  Mastercycler® 
personal) with the following cycles: 25˚C for 10 minutes, 37˚C for 60 minutes, 
95˚C for 5 minutes.  The complementary DNA (cDNA) was stored at -20˚C until 
use for qRT-PCR. 
 
Quantitative real-time Polymerase Chain Reaction  
The polymerase chain reaction was utilized to exponentially amplify DNA 
primer templates of interest.  The cDNA samples were diluted with RNase-free 
water for a 1:50 ratio.  In each quantitative real-time Polymerase Chain reaction 
(qRT-PCR) reaction, 9 µl of dilute cDNA was added to 10 µl Universal PCR 
Master Mix (Applied Biosystems®) and 1 µl of primer set.  Each 96-well plate 
was covered with a clear film (Applied Biosystems®) and gently spun down in a 
centrifuge at 1500 rpm for 2 minutes to eliminate any bubbles.  The qRT-PCR 
reaction was performed using ABI 7700 Sequence Detector®.  The qRT-PCR 
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reaction was set up as follows: 50˚C for 2 minutes, 95˚C for 10 minutes, 95˚C for 
15 seconds, 60˚C for 1 minute.  The PCR amplification was completed for a total 
of 40 cycles.  Each sample was run in triplicate and normalized to 18s rRNA to 
permit correction for sample-to-sample variations in starting amounts of total 
RNA.  Sample threshold cycle (CT) values were normalized to the threshold 
value for 18s for each timepoint (∆CT  = X CT (gene) – X CT (18s)).  Expression was 
then normalized to B6 mice at day 0 to allow for comparisons across the three 
different strains, as well as to the individual strain at day 0 to view expression 
patterns for each strain alone (∆∆CT = X CT (gene) – X CT (gene 0d)).  Using day 0 as 
a reference, fold change in expression for the different mRNAs were graphed   
(2-∆∆CT, where B6 day 0 = 1).  
 
Micro-Computed Tomography 
Fracture calluses from all three strains (AJ n= 9; B6 n=11; C3 n=11) at 
21d post fracture were scanned with a micro-computed tomography (µCT) 
system (µCT 40, Scanco Medical, Brüttisellen, Switzerland) at medium resolution 
with a 12 µm isotropic voxel size (70 kVp, 114 mA).  The femur was wrapped in 
packing Styrofoam before being placed in the scanning tube to keep the sample 
from moving while in the scanner.  The tube was then filled with 1x PBS to 
prevent the sample from dying out.  The locations of the proximal and distal ends 
of the callus were set as the boundaries for the scan.  After the scan, the region 
of cortical bone was identified from a 120 micron region (10 slices x 12µm) from 
 28 
each 2D tomograph to define a threshold value that corresponds to mineralized 
tissue for each of the three stains (Figure 5A, 5B).  The outer  
 
Figure 5.  Segmentation for threshold identification.  Representative images for identifying 
threshold values.  A. Segmentation of cortical bone to determine the threshold value for that 
corresponds to mature cortical bone mineralization.  B. Resultant binary image after applying a 
fixed threshold of 25% of the maximum voxel intensity.  C. Segmentation of the callus that 
corresponds to mineralized callus tissue based on 45% of mature cortical bone.  D. Resultant 
binary image after applying a threshold of 45% of mature cortical bone.  The outer green contours 
represent inclusion boundaries to include pixels within the boundary, while the inner red contours 
represent exclusion boundaries to exclude pixels within the boundary.   
 
1 mm 1 mm 
1 mm 1 mm 
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boundary of the callus was also identified from each 2D tomograph, by including 
the callus area and excluding the inner cortical area, to define the volume of 
interest (Figure 5C, 5D).  A previous study indicated that the threshold value for 
mineralized tissue (vs. unmineralized and poorly mineralized tissue) is 45% of 
mature cortical bone (Morgan et al., 2009).  The mean value from 45% of the 
threshold for each strain was used to set a strain specific threshold value.   
 The phenotypic properties measured from µCT were total volume (TV), 
mineralized volume (BV), mineralized volume fraction (BV/TV), tissue mineral 
density (TMD), standard deviation of tissue mineral density (TMD.sd), and bone 
mineral density (BMD) (Table 3).  These calculations were made based on the 
premise that the X-ray attenuation of mineralized bone was determined by the 
amount of calcium hydroxyapatite (HA) (Ca5(PO4)3(OH)), the mineral compound 
of bone.  By establishing a calibration between the mass concentration of 
hydroxyapatite and the attenuation coefficient using phantoms with known 
densities of hydroxyapatite (100, 200, 400, and 800 mg HA/cm3), we were able to 
convert intensities to equivalent measures of bone mineral density (mg HA/cm3).   
Furthermore, the effective polar moment of inertia (Jeff) was computer 
(custom script, Matlab 7.12 (R2011a), The Mathworks, Natick, MA) for each 
callus.  Because the shape of the callus was not uniform along the length of the 
callus and varied as the callus tapered away from the fracture line, we made our 
calculations of Jeff by assuming that the shear modulus was fixed across the 
callus.  Also, due to the porosity of the callus, we approximated the cross-
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sectional shapes of the callus to be circular.  First, we determined the polar 
moment of inertia (Ji) of each 2D tomograph generated by the µCT scan using 
the equation: 
 =
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in which all N voxels whose intensity was greater than the applied threshold 
(idenifying mineralized tissue) were summed.  This included cortical bone and 
mineralized tissue.  rk is the space between voxel k and the center of mass of 
each 2D tomograph.  A is defined as the transverse cross-sectional area of each 
voxel, which is 144 µm2.  The Ji for all 2D tomographs in a given sample where 
then used to calculate the effective polar moment of inertia (Jeff) using the 
equation: 
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where L represents the callus length.  J(z) is the Ji from each 2D tomograph 
located at the logitudical position z.  The attenuation-weighted, effective polar 
moment of inertia, Jeff,w, was also determined for each sample using the same 
method described, however when calculating Ji, the intensity of the voxel was 
scaled to the maximum intensity found within the given sample.  Samples with 
unsuccessful harvests, in which the fractured bone was in two pieces, were 
excluded from analysis (AJ n = 2). 
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Table 3.  Callus structural properties measured from µCT.  Explanation of structural 
properties of fracture calluses obtained from µCT evaluations.   
 
 
 
Mechanical Testing 
Immediately after the femora were analyzed with µCT, they were tested 
using a torsional testing system (MT55, Instron, Norwood, MA).  The proximal 
and distal ends were embedded in polymethyl methyacrylate (PMMA) and 
square aluminum cubes (10 x 10 mm2).  A custom apparatus was set up to keep 
the bone centered in the PMMA and aluminum cubes during the curing process.  
Exposed bone and callus was wrapped in 1x PBS soaked gauze to keep the 
sample from drying out while the PMMA was curing.  The gauge length of the 
sample was measured between the two ends of the PMMA, and from all 4 sides 
of the square cube.  The calculated average was determined for each sample, 
and defined as the sample specific gauge length.  The sample was loaded in the 
torsion testing device and secured in place by adjusting the grips that hold the 
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cubes in place.  Biomechanical properties that were obtained from torsional 
testing are shown in Figure 6.  Angular displacement, or twist, was set at 
0.5˚/second until the fracture callus broke, which was defined as failure.  Since 
right femurs were tested, the device was programmed to apply a rotation such 
that the distal end twisted inward relative to the proximal end.  Fracture callus 
strength was determined from the maximum torque supported by the callus.  
Stiffness was determined from the slope of the linear region of the torque-twist 
plots.  Rigidity was determined from multiplying torsional stiffness by gauge 
length.  Distal and unstable fracture calluses were excluded from mechanical 
testing due to the inability to properly secure both ends of the bone in PMMA (AJ 
n = 1; C3 n=2).   
 
Figure 6.  Torque-twist curve.  Torque-twist curve showing biomechanical measurements 
computed following torsional mechanical testing.  Maximum torque (strength) and twist to failure 
(angular displacement) were measured at the failure point of the callus. Stiffness was calculated 
by identifying the slope of linear region of the curve.  Work to failure (toughness) was calculated 
by integrating the area under the torque-twist curve to the point of failure. 
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Contrast-Enhanced Micro-Computed Tomography 
Fracture calluses harvested at post fracture day 21 were used for 
contrast-enhanced µCT (CECT).  An initial µCT scan (medium resolution, 12 µm 
isotropic voxel size, 70 kVp, 114 mA) was performed on each sample before 
soaking in a contrast agent.  The scan tube was filled with a PBS, Pen Strep, and 
protease inhibitor solution (45 ml 1x PBS, 450 µl penicillin streptomycin strep, 1 
tablet protease inhibitor) to slow down tissue decomposition.  To ensure optimal 
alignment of bones during both pre- and post-contrast scans, a custom-made 
cap was used, which would secure the bone and assist with alignment within the 
tube for both scan set-ups.  The start position of the pre-contrast scan was noted.  
Immediately after the pre-contrast scan, the bone was fully submerged in a 
cationic iodinated contrast agent, CA4+ (dilute, 27mg I/ml, CA4+ in PBS, pH = 7.4) 
for 8 hours at room temperature.  After 8 hours, the sample was scanned again 
using the start position of the pre-contrast scan.  The tomographs generated from 
the pre- and post-contrast scans were transferred into an image analysis 
software (Amira 5.5, Visage Imaging, Andover, MA).  Both images were brought 
into alignment using manual transformation followed by affine registration using 
an optimization algorithm.   
After performing the registration computation, the pre-contrast tomographs 
were subtracted from the post-contrast registered tomographs using an 
arithmetic function in Amira.  Thresholds were determined by examination of 
histograms of the intensities generated from the subtraction image (Figure 7).  
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The histogram was broken down into three or four constituent parts that 
represent intensities related to background noise, PBS and noncartilagenous soft 
tissues, cartilage, and in some samples, bone that was not removed from the 
subtraction.  The histograms were fit with normal distribution curves based on the 
Gaussian model (custom script, Matlab 7.12 (R2011a), The Mathworks, Natick, 
MA).  The resulting thresholds were applied to the subtraction images to exclude 
background noise, callus, and any cortex remaining due to errors in the 
registration process.  In samples where no cortical bone remained after 
registration, only a cartilage threshold was determined, which was chosen so that 
there was a 95% probability that the intensity of voxels greater than the threshold 
were cartilaginous tissue.  Samples that contained cortical bone after the 
registration had a forth, or upper threshold.  In these samples, a lower and upper 
threshold for cartilage had to be determined.  The lower threshold for cartilage 
was determined so that it would have a 95% probability that the given threshold 
predicted voxels with an intensity that belonged to cartilage, while the upper 
threshold was determined to exclude cortical bone with 50% probability.   
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Histograms 
 
Figure 7. Representative histograms and probability plots for determining CECT 
thresholds.  The images on the top illustrate Gaussian Curve fitting for histograms of intensities 
of voxels generated for the subtraction of the pre-contrast image and post-contrast image.  The 
images on the bottom illustrate probability plots for intensities corresponding to tissue type.  The 
left column is an example of a three constituent part fit, and the right column is an example of a 
four constituent part fit.  The teal lines represent background noise, the red lines represent PBS 
and noncartilagenous soft tissues, the green lines represent cartilaginous tissue, the black line 
represents bone, and the pink line is a sum of all curves.  The blue horizontal line in the 
probability plots represents the probability of 0.95.  
 
 
The final image generated from the subtraction and applying the 
determined threshold was used to generate a 3D representation of the 
cartilaginous regions in each sample.  To evaluate the structure of the cartilage 
within the callus, a group of 15 transverse images, separated by 250 µm and 
ranging 1750 µm from both the proximal and distal ends of the fracture gap were 
evaluated.  The image resulting from the subtraction of the pre-contrast agent 
scan and post-contrast agent scan was loosely segmented by contouring to 
identify the boundary of the callus (Figure 8A).  The resulting contour was applied 
to the pre-contrast agent image and the cortex was excluded by an additional 
Probability 
Plots 
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contour to identify the region containing only callus (Figure 8B).  Lastly, the 
contours from the pre-contrast agent were applied to the image resulting from 
applying the threshold that was determined to contain cartilage to identify the 
region of callus that contained cartilage (Figure 8C).  The cartilage volume, 
cartilage volume per length, callus tissue mineral density, standard deviation of 
mineral density, and callus bone mineral content were determined (Table 4).  
 
 
Figure 8.  Segmentation for callus mineralization and cartilage identification.  Sample 
images for identifying boundaries of the callus that contained mineralized tissue and cartilaginous 
tissue for structural analysis.  A. Segmentation of the callus boundary of the resultant image from 
subtraction of pre-contrast agent scan and post-contrast agent scan.  B. Segmentation of the 
callus boundary with exclusion of cortical bone.  C. Segmentation of the callus that contains 
cartilage by application of contours from B.  The outer green contours represent inclusion 
boundaries to include pixels within the boundary, while the inner red contours represent exclusion 
boundaries to exclude pixels within the boundary. 
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Table 4.  Callus structural properties measured from CECT.  Explanation of structural 
properties of fracture calluses obtained from CECT evaluations.   
 
 
Data Analysis 
The mean values and standard deviations of the mean were calculated for 
each property and strain measured.  All comparisons were made using a 
parametric, one-way Analysis of Variance (ANOVA) to examine differences 
among the three strains of mice at a significance of α = 0.05.  Post hoc 
comparisons using Tukey HSD tests were performed following the ANOVAs to 
test for differences between each strain also at a significance of α = 0.05.   
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RESULTS 
 
 
Temporal Gene Expression during Fracture Healing 
qRT-PCR was utilized to evaluate the relative progression towards new 
bone formation in fractured calluses at various timepoints throughout the healing 
process.  In order to gain a comparable sense of both the relative differences in 
the expression profiles between strains and within an individual strain, the 
expression was either made in reference in all strains to the unfractured B6 
levels or to the strains own levels of expression in the unfractured bone.  Two 
transcription factors that regulate embryonic stem cell self-renewal and 
pluripotency that have been associated with post natal skeletal stem cells (Bais 
et al., 2012; Gagiliardi et al., 2013; Seo, Basu-Roy, Zavadil, Basilico & 
Mansukhani, 2011) were analyzed: Sox2 and Nanog (Figure 9).  Interestingly, 
the pattern of expression of Sox2 and Nanog were almost identical within the 
strains.  Both C3 and B6 strains showed an early peak of expression at day 5 
post fracture, while AJ did not.  B6 also showed a more prolonged expression for 
both genes throughout the period of primary and secondary bone formation 
compared to either AJ or C3 strains and only showed a decreasing expression 
after day 18.  In contrast, C3 had two distinct peaks of increased expression at 5 
and 14 days after fracture, after which the expression of both genes returned 
close to their base line of expression, while AJ strain showed only a single 
distinct peak in the expression of these genes at 18 days after fracture. 
 39 
 
 
 
Figure 9. Relative temporal profiling of stem cell mRNA expression.  Transcription factors 
regulating pluripotent stem cells: Sox2 and Nanog.  The top left graph of each gene show relative 
expression to B6 at day 0.  The graphs plotting a single strain each show relative expression to 
each individual strain at day 0.  Each data point represents the mean fold change at the specified 
timepoint post fracture for each stain.  Error bars indicate 1 SD of the mean.  Letters grouped 
together over individual timepoints indicate strains that were statistically different from each other, 
with the first letter indicating higher expression compared to the second letter.   
 
Next, we assessed the expression of various mRNAs associated with the 
differentiation and development of cartilage: Sox9, Collagen type II alpha 1 
(Col2a1), Aggrecan (Acan), and the development of chondrocyte hypertrophy: 
Sox2 
Nanog 
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Collagen type X alpha 1 (Col10a1), and Parathyroid hormone-like hormone 
(PTHrp) (Figure 10, 11, 12).  First we compared the gene expression of genes 
associated with early commitment and progression of the chondrocyte linage 
(Sox9, Col2a1, and Acan) and then two genes, one that maintains proliferation 
(PTHrp) in comparison to one associated with terminal stages of hypertrophy 
(Col10a1).  A comparison of Sox9 expression showed that all strains reached 
their peak expression on day 7 however; AJ levels began to rise later than the 
other two strains and maintained a level near its peak significantly longer than C3 
and B6.  By day 14, all strains were near day 0 levels.  A comparison of Col2a1 
expression between strains showed a significant difference between AJ, C3, and 
B6 with C3 having a higher relative level of expression over AJ and B6 earlier at 
day 5.  While both C3 and AJ showed peak expression by day 7, B6 peaked at 
day 10.  However at day 7, AJ had a significantly higher level of expression than 
either C3 or B6.  All strains exhibited about the same length of time for the 
expression of Acan, although C3 again had the highest and earliest expression 
for this gene of all three strains.  There was also a significantly higher level of 
expression of Acan in C3 compared to AJ at day 5 post fracture. 
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Figure 10. Relative temporal profiling of chondrogenic mRNA expression I.  Transcription 
factors regulating chondrogenesis: Sox9 and Collagen type II.  The top left graph of each gene 
show relative expression to B6 at day 0.  The graphs plotting a single strain each show relative 
expression to each individual strain at day 0.  Each data point represents the mean fold change at 
the specified timepoint post fracture for each stain.  Error bars indicate 1 SD of the mean.  Letters 
grouped together over individual timepoints indicate strains that were statistically different from 
each other, with the first letter indicating higher expression compared to the second letter. 
Sox9 
Col2a1 
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Figure 11. Relative temporal profiling of chondrogenic mRNA expression II.  Transcription 
factors regulating chondrogenesis: Aggrecan.  The top left graph of each gene show relative 
expression to B6 at day 0.  The graphs plotting a single strain each show relative expression to 
each individual strain at day 0.  Each data point represents the mean fold change at the specified 
timepoint post fracture for each stain.  Error bars indicate 1 SD of the mean.  Letters grouped 
together over individual timepoints indicate strains that were statistically different from each other, 
with the first letter indicating higher expression compared to the second letter. 
 
 
The expression of PTHrp and Col10a1 was next examined.  Interestingly, 
PTHrp was only significantly different at day 0, with C3 exhibiting a greater level 
than both AJ and B6.  Furthermore, C3 also showed greater expression 
compared to AJ at day 5.  Thus, C3 showed earlier expression of PTHrp than AJ 
and B6.  B6 had a longer duration of increased expression compared to AJ and 
C3, which both had comparable durations.  The levels of expression of Col10a1 
were very similar across all strains, with the exception of the baseline at day 0.  
At this timepoint, C3 also showed significantly greater baseline levels of 
expression compared to B6 as well as a trend of greater expression compared to 
AJ.  There was also a trend of higher levels of expression at day 5 in C3 
compared to AJ.  While all strains had increased levels of expression for about 8 
Acan 
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days, which began at day 5 and tapered off to pre-fracture levels by day 14, C3 
showed an earlier decline after day 7. 
 
 
Figure 12. Relative temporal profiling of chondrogenic mRNA expression III.  Transcription 
factors regulating chondrogenesis: Parathyroid hormone like-hormone and Collagen type X.  The 
top left graph of each gene show relative expression to B6 at day 0.  The graphs plotting a single 
strain each show relative expression to each individual strain at day 0.  Each data point 
represents the mean fold change at the specified timepoint post fracture for each stain.  Error 
bars indicate 1 SD of the mean.  Letters grouped together over individual timepoints indicate 
strains that were statistically different from each other, with the first letter indicating higher 
expression compared to the second letter. 
 
 
 
Col10a1 
PTHrp 
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 The maturation and differentiation of osteoblasts was analyzed next 
across the three strains.  In these studies three genes, osterix (Osx), Osteocalcin 
(Ocn) and dentin matrix acidic phosphoprotein 1 (Dmp1) were assessed, which 
span the differentiation of the osteoblast to the terminal osteocyte stage (Figure 
13, 14).  The patterns of expression of osteogenic genes were less similar for the 
three strains than were observed for the chondrogenic genes.  Beginning with 
day 0, C3 had a significantly higher baseline expression of Osx than B6, with AJ 
also showing a trend toward higher baseline expression than B6.  At day 3, all 
three strains began to increase their levels of Osx expression and by day 7, AJ 
had a significantly higher expression of Osx than B6, with C3 also showing a 
trend towards a higher expression over B6.  Between day 7 and 10, the levels of 
Osx in all strains began to rise with C3 showing a significantly higher level than 
B6 at day 14 and a higher expression compared to AJ.  AJ continued to express 
a higher relative level of expression than B6 at 18 days post fracture with the 
levels of expression in all strains beginning to decline at this time.  However, C3 
continued to show higher expression than B6 at day 28.  A comparison of Ocn 
expression between the three strains revealed similar patterns of expression.  
The levels began to rise between days 7 and 10, and were nearly maintained 
through day 35.  Again there was a trend of a greater expression of Ocn in C3 
compared to B6, suggesting that B6 levels were not increasing as early as C3. 
Significant differences were seen between C3 and both AJ and B6 at days 28 
and 35.  C3 maintained significantly higher levels of expression than both these  
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Figure 13. Relative temporal profiling of osteogenic mRNA expression I.  Transcription 
factors regulating osteogenesis: Osterix and Osteocalcin.  The top left graph of each gene show 
relative expression to B6 at day 0.  The graphs plotting a single strain each show relative 
expression to each individual strain at day 0. Each data point represents the mean fold change at 
the specified timepoint post fracture for each stain.  Error bars indicate 1 SD of the mean.  Letters 
grouped together over individual timepoints indicate strains that were statistically different from 
each other, with the first letter indicating higher expression compared to the second letter. 
 
 
 
Osx 
Ocn 
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Figure 14. Relative temporal profiling of osteogenic mRNA expression II.  Transcription 
factors regulating osteogenesis: Dentin Matrix Acidic Phosphoprotein 1.  The top left graph of 
each gene show relative expression to B6 at day 0.  The graphs plotting a single strain each 
show relative expression to each individual strain at day 0.  Each data point represents the mean 
fold change at the specified timepoint post fracture for each stain.  Error bars indicate 1 SD of the 
mean.  Letters grouped together over individual timepoints indicate strains that were statistically 
different from each other, with the first letter indicating higher expression compared to the second 
letter. 
 
strains.  Perhaps the most striking difference between the strains was the level of 
expression of Dmp1 in B6 compared to AJ and C3.  Throughout the course of the 
study, B6 displayed a much higher level of expression.  All strains began their 
first peak around day 7, while C3’s second peak occurred on day 14, AJ’s on day 
18, and B6’s on day 28.  Therefore, all three strains exhibited two peaks in 
expression.  Throughout the course of the study, B6 displayed much higher 
levels of relative expression with significantly higher levels than both AJ and C3 
throughout most of the time course.  The levels and pattern of expression of 
Dmp1 between AJ and C3 were very comparable and thus, non-significant at all 
timepoints. 
Dmp1 
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Micro-Computed Tomography at Day 21 Post Fracture 
 
 Micro-computed tomography was used to evaluate the structural and 
material properties, as well as the spatial distribution of the mineral from mid-
diaphaseal fractures of each of the three strains of mice (Figure 15, 16).  The 
µCT images also showed clearly distinguishable differences in the traits of the 
newly formed callus tissue between the three strains. The greatest distinction 
was the region of low X-ray attenuation near the fracture gap of the C3 callus at 
day 21 post fracture.  The paucity of mineralized tissue in this central region is 
characteristic of residue cartilage tissue and a lack of bony bridge between the 
fracture fragments.   
 Significant differences in callus total volume was observed when B6 was 
compared to AJ and C3, where the B6 callus was 63% larger than AJ (p < 
0.0001) and 47% larger than C3 (p < 0.0001).  In contrast, no significant 
differences in total volume were seen between AJ and C3 calluses (p > 0.2744).  
B6 also exhibited a significantly larger callus bone volume than AJ and C3.  AJ 
bone volume was 63% lower than B6 (p < 0.0001), whereas C3 bone volume 
was 46% lower than B6 (p < 0.003).  Bone volume fractions were not statistically 
different between AJ, B6, or C3 (p > 0.6704).  However, bone mineral density 
was found to be greater in AJ compared to B6.  The bone density in AJ was 
about 15% greater than B6 (p = 0.0463), but no different than C3 (p > 0.3377).  
There was no difference between B6 and C3 (p > 0.5016).  Tissue mineral 
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Figure 15.  Three-dimensional reconstruction of fractured femora scanned by µCT at Day 
21 post fracture.  Images are representative of each strain determined from the strain mean 
parameters measured (BV, TV, BV/TV, TMD and BMD).  The left column contains images from 
AJ, the middle column contains images from B6, and the right column contains images from C3.  
From top to bottom, 3D whole callus images, 3D frontal plane images, 3D transverse images 
through the fracture gap, 2D transverse images through the fracture gap.  The orange color 
indicates the cut surface. 
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Figure 16.  Quantitative µCT analysis of fracture callus at day 21 post fracture.  Column 
heights indicate strain means for each of the callus phenotypic parameters measured: A. bone 
volume, B. total volume, C. volume fraction D. bone mineral density, E. tissue mineral density, F. 
standard deviation of tissue mineral density, G. effective polar moment of inertia, and H. 
weighted, effective polar moment of inertia.  Levels not connected by the same letter are 
significantly different, p < 0.05.  Error bars indicate 1 SD of the mean. 
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density of fracture calluses was 10% more in AJ compared to B6 (p < 0.0001) 
and 4% more in AJ compared to C3 (p = 0.0244) calluses.  The standard 
deviations of tissue mineral density were not statistically different between the 
three strains (p > 0.1873).  B6 exhibited a greater effective polar moment of 
inertia than AJ (p < 0.0001) and C3 (p = 0.0005), while there was no difference 
between AJ and C3.  B6 also had a greater weighted, effective polar moment of 
inertia than AJ (p = 0.0004) and C3 (p = 0.0014), while there was no difference 
between AJ and C3. 
 
Biomechanical Properties at Day 21 Post Fracture 
 
To assess biomechanical properties, torsional tests to failure were 
performed on post fracture day 21 femora from the three inbred strains of mice 
(Figure 17).  A significant difference in angular displacement, or twist to failure, 
was observed between AJ and B6 femora, with AJ showing a greater 
displacement by approximately 50% (p = 0.0209).  However, C3 showed a trend 
of having a greater angular displacement compared to B6 (p = 0.0738).  The 
toughness, or work to failure, was significantly higher in C3 compared to B6 (p = 
0.0130), but no difference was found between AJ and B6, and AJ and C3.  In a 
comparison of AJ to B6, AJ displayed a trend of greater toughness (p = 0.1895).  
Among the three strains of mice, there were no significant differences in strength, 
stiffness, or rigidity.  However, there were trends toward B6 showing a greater 
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Figure 17. Biomechanical properties day 21 post fracture.  Column heights indicate strain 
means for each of the biomechanical parameters measured: A. strength, B. angular 
displacement, C. toughness, D. stiffness, and E. rigidity.  Levels not connected by the same letter 
are significantly different, p < 0.05.  Error bars indicate 1 SD of the mean. 
 
rigidity compared to AJ (p = 0.0992) and C3 (p = 0.1051).  In addition, B6 
exhibited a trend showing a greater degree of stiffness over AJ (p = 0.1274).   
 
Contrast-Enhanced Micro-Computed Tomography at Day 21 Post Fracture 
 
 The concurrent analysis of cartilage and mineralized tissue in the fracture 
callus was achieved through contrast-enhanced micro-computed tomography at 
day 21 post fracture.  The CECT images showed small amounts of cartilage 
remaining in three strains of calluses and appeared as a wedge within the 
0
0.01
0.02
0.03
0.04
0.05
AJ B6 C3
M
ax
 
To
rq
u
e 
[N
m
]
Strength
0
0.1
0.2
0.3
0.4
AJ B6 C3
An
gu
la
r 
D
is
pl
ac
em
en
t 
[ra
d]
Twist to Failure
0
0.002
0.004
0.006
0.008
0.01
AJ B6 C3
W
o
rk
 
to
 
Fa
ilu
re
 
 
[N
m
-
ra
d]
Toughness
0
0.1
0.2
0.3
0.4
0.5
0.6
AJ B6 C3
St
iff
n
es
s 
[N
m
/ra
d]
Stiffness
0
0.02
0.04
0.06
0.08
0.1
0.12
AJ B6 C3
R
ig
id
ity
 
[N
/ra
d]
Rigidity
A B C 
D E 
 A 
A 
  A 
 A 
 A 
A 
  A 
B 
A,B 
  A,B 
B 
 A 
A 
A 
A 
 52 
fracture gap of C3 (Figure 18).  The CECT analysis indicated that there is no 
difference in the amount of cartilaginous soft callus area between the AJ, B6, and 
C3 (Figure 19A).  However, it also showed that the distribution of cartilage 
around the fracture gap was greatest adjacent to the gap and gradually 
decreased toward the proximal and distal ends (Figure 19A).  For cartilage 
 
 
 
Figure 18.  Three-dimensional reconstruction of fractured femora scanned by µCT with a 
cationic contrast agent.  Images are representative of each strain determined from strain mean 
parameters measured (Cartilage and Callus Volume, TMD and BMC).  The left column contains 
an image from AJ, the middle column contains an image from B6, and the right column contains 
an image from C3.  Mineralized bone tissue is shown in brown and cartilage tissue is shown in 
pink 
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Figure 19.  Distribution of cartilage and mineralization around the fracture gap.  A stack of 
15 transverse slices, separated by 250 µm and together extending 1750 µm proximal to 1750 µm 
distal from the fracture gap (x = 0) was used to determine the spatial distribution of A. cartilage 
soft callus and B. mineralized tissue within the entire fracture callus.  Each data point represents 
the mean area within the specified region for each stain.  Error bars indicate 1 SD of the mean. 
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Figure 20.  Quantitative CECT analysis of fracture callus cartilage at day 21 post fracture.  
Column heights indicate strain means for each of the biomechanical parameters measured; A. 
callus cartilage volume and B. callus cartilage volume per length.  Levels not connected by the 
same letter are significantly different, p < 0.05.  Error bars indicate 1 SD of the mean. 
 
 
CECT evaluations, there were no differences in cartilage volume between strains 
(p > 0.4954) (Figure 20A).  There was also no difference in cartilage volume per 
length of callus between strains (p > 0.8036) (Figure 20B). 
 In agreement with our results from µCT, the callus mineralized tissue 
volume was greater in B6 compared to AJ (p < 0.0001) and C3 (p < 0.0001) 
(Figure 21A).  In addition, the volume of mineralized tissue per given length of 
the callus was also significantly greater in B6 compared to AJ (p < 0.0001) and 
C3 (p < 0.0001) (Figure 21B).  A graph of the area of mineralization within the 
callus at different locations around the fracture gap was also consistent with 
these results (Figure 19B).  Also consistent with our µCT results, the tissue 
mineral density of the callus was about 6% greater in AJ over C3 (p = 0.0459) 
(Figure 21C).  The tissue mineral density was about 8% greater in B6 compared 
to C3 (p = 0.0206), which was opposite than our results of µCT.  No significant 
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differences in standard deviation of callus tissue mineral density was found 
between the three strains (p > 0.5387) (Figure 21D).  The pattern of bone mineral 
content within the calluses of the three strains was also consistent with our 
findings from µCT (Figure 21E).  Bone mineral content was also found to be 
greater in B6 compared to AJ and C3.  The bone content in B6 was about 64% 
greater than AJ (p < 0.0001) and 54% greater than C3 (p < 0.0001). 
 
  
   
Figure 21. Quantitative CECT analysis of fracture callus mineralization at day 21 post 
fracture.  Column heights indicate strain means for each of the biomechanical parameters 
measured: A. callus mineralized tissue volume, B. callus mineralized tissue per length, C. callus 
tissue mineral density, D. callus standard deviation of tissue mineral density, and E. callus bone 
mineral content.  Levels not connected by the same letter are significantly different, p < 0.05.  
Error bars indicate 1 SD of the mean. 
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DISCUSSION 
 
 
The idea that bone regeneration is a complex trait and has the capacity to 
bring together different complements of molecular and cellular interactions to 
carry out its necessary mechanical functions is attributable to the effects of 
genetic variations on both bone morphology, BMD, and mechanical competency 
(Jepsen, 2007; Manigrasso & O’Connor, 2008).  The data presented here 
revealed that the process of fracture healing also varied among different genetic 
backgrounds.  The features of callus formation that varied between the three 
genetic backgrounds can be associated to the patterns of temporal gene 
expression and phenotypic properties (structural, material, and biomechanical) of 
the fracture callus tissue and whole bone. 
 The comparison of mRNA expressions between the three strains revealed 
striking differences.  In prior studies, transcription factors that regulate pluripotent 
stem cells (Sox2 and Nanog) have been shown to contribute to the maintenance 
of pluripotent stem cells of the osteoblastic lineage, while Nanog is involved in 
the maintenance and differentiation of post natal marrow stromal cell populations 
(Bais et al., 2012; Gagliardi et al., 2013; Seo et al., 2011).  We found that the 
patterns of these mRNAs followed almost identical temporal patterns, which may 
be explained by the direct interaction between both genes (Gagliardi et al., 
2013).  The C3 strain had the earliest induction of these markers, the AJ strain 
had the latest, and the B6 strain had an intermediate time.  Furthermore, AJ 
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showed monophasic expression, while the C3 showed biphasic expression, and 
the B6 showed triphasic expression.  In this regard, the stem cell populations that 
are maintained in the post natal bone may retain their embryological gene 
expression template as they are activated and renewed during bone regeneration 
since their patterns are unique to the strain. 
 In our next comparison of genes, we investigated expression of marker 
genes that regulate cartilage formation.  Sox9, which is expressed by MSCs that 
are committed to bone development, induces chondrocyte maturation and 
inhibits osteogenesis by inhibiting osteoblast differentiation (Leung et al., 2011).  
The production of aggrecan, a major structural proteoglycan component of the 
ECM of cartilage, is regulated by the gene Acan (Hiltunen, Aro, & Vuorio, 1993).  
Col2a1 is a transcription factor that is responsible for the production of type II 
collagen found in cartilagenous tissue.  Collagen type II confers the tensile 
strength of the ECM and is expressed during cartilage condensation (Leung et 
al., 2011).  Another collagen providing tensile strength is collagen type X.  
Col10a1 is responsible for producing collagen type X, and is expressed by 
hypertrophic chondrocytes during calcification of the cartilage, a process also 
known as endochondral ossification (Leung et al., 2011; Iyama et al., 1991).  
Lastly, parathyroid hormone-like hormone (PTHrp) functions to keep hypertrophic 
chondrocytes in the chondrogenic cell cycle by preventing them from entering 
osteoblastic differentiation (Kronenburg, 2007).  The expression patterns of each 
of these genes revealed that B6 were the first to initiate chondrogenesis.  B6 
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expressed the greatest relative amount of all chondrogenic genes under this 
study.  B6 also had the longest duration of chondrocyte maturation, suggesting 
that divergent differentiation of skeletal progenitors in B6 experienced a longer 
duration of cartilage development compared to AJ and C3.  C3 had the shortest 
period of chondrogenesis as indicated by the markers for the late stages of 
chondrogenesis.  Our results indicated that AJ showed a slower chondrogenic 
development than B6 and C3, but almost identical pattern of endochondral 
ossification to the B6 mice, indicating that it progressed in healing faster than C3.  
A previous study indicated that AJ most closely resembled the chondrogenic 
temporal pattern of C3, which was also indicated by our results (Jepsen et al., 
2008).  This was important due to the fact that the current study included 
investigation of more timepoints, which offered a greater resolution in the 
temporal expression of specific gene products.  
 In our final group of gene expression, we investigated genes related to 
bone formation, or osteogenesis.  The differentiation of MSCs to mature 
osteoblasts, and degradation of chondrogenic matrices is regulated by Osx 
(Nakashima et al., 2002).  Osteocalcin is secreted by osteoblasts, and was used 
in this study as a reliable maker of osteogenesis (Cox, Einhorn, Tzioupis, & 
Giannoudis, 2010).  The final gene expression profiled was Dmp1, which is 
expressed by osteocytes in woven and lamellar bone (MacDougall, Gu, Luan, 
Simmons, & Chen, 1998).  Although all three strains showed the same time 
period of calcification and degradation of the cartilage matrices, AJ appeared to 
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have a more robust initiation much sooner than C3 and B6, suggesting that 
osteogenic differentiation overlapped more with chondrogenesis.  C3 showed the 
earliest induction of osteogenesis, suggested by the temporal expression of 
PTHrp, which peaked earlier and decreased earlier than AJ and B6, as well as a 
greater amount of relative expression compared to both strains.  Together with 
the chondrogenic development mentioned earlier, both of these findings showed 
that C3 had the shortest duration of chondrogenesis and earliest onset of 
osteogenesis.  The later expression of Ocn and Dmp1 by both AJ and B6, 
compared to C3, suggested a later commitment to bone formation.  This could 
also be indicative that there was more synchronization of resorption during 
endochondral ossification and the following process of primary bone formation in 
AJ and B6.  In contrast, C3 expression of osteogenic genes occurred after the 
peak of expression of chondrogenic genes, suggesting there was less overlap 
between these 2 stages of fracture healing. 
 The mRNA comparison between strains provided insight into the variation 
of fracture healing due to genetic background.  The findings from gene analysis 
showed that AJ and B6 healed faster than C3.  While B6 had an earlier and 
longer duration of chondrogenesis, C3 had a briefer duration of cartilage 
formation, subsequent tissue mineralization and initiated primary bone formation 
earlier. 
µCT was carried out to characterize the differences in callus structure at 
day 21 post fracture.  The differences in mineralization density observed by 3D 
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µCT image reconstructions indicated that the bone within the fracture gap region 
of C3 calluses had the least amount of mineralization compared to both AJ and 
B6.  The results obtained from CECT analysis support this finding, which 
suggested that this central region of the callus still contained cartilage that had 
not yet been mineralized.  Furthermore, the bone that bridges the fragments of 
the fracture developed and mineralized at a slower rate than AJ and B6.   
The use of a cationic contrast agent with µCT allowed the visualization 
and 3D reconstruction of cartilage in fracture calluses during the transition 
between the soft callus and hard callus stages.  At day 21 post fracture, no 
aggregations of cartilaginous tissue were visible in the calluses, with the 
exception of cartilage that remained in the fracture gap of C3.  The lack of a large 
presence of cartilage identified through CECT matched that previously described 
in literature through more common histomorphometric assessments (Jepsen et 
al., 2008; Manigrasso & O’Connor, 2008).  Additionally, CECT analysis allowed a 
simultaneous, measurable determination of cartilaginous and mineralized callus 
tissue, and allowed the 3D visualization of both tissues together within the 
fracture callus through a nondestructive method. 
The comparison of µCT and mechanical test data was also consistent with 
the lack of or poorly formed bridging callus.  Although the stiffness between the 
strains in this study did not differ, the use of previously published data on 
unfractured femora was consistent with these findings.  The stiffness of intact, 
unfractured femora have been reported to be 380 ± 30 Nmm/rad for AJ, 640 ± 
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60 Nmm/rad for B6, and 870 ± 290 Nmm/rad for C3, given as mean ± SD 
(Jepsen et al., 2008).  From this, we can see that C3 had a much lower stiffness 
at day 21 post fracture compared to nonfractured controls.  Using the reported 
unfractured values from Jepsen et al. (2008) and our current fracture data, C3 
regained 37% of stiffness by day 21.  In contrast, AJ and B6, which have more 
developed bridging calluses, have regained most of their pre-fracture stiffness, 
68% and 72%, respectively.   
 A comparison of gene expression, µCT, torsional testing, and CECT 
analysis consistently showed that B6 developed a larger callus than AJ and C3.  
The greater expression of cartilage genes suggested more cartilage protein 
products, and thus, a larger cartilage anlage on which subsequent bone tissues 
could be modeled.  The rigidity of B6 callus was trending toward greater 
resistance toward deformation compared to both AJ and C3.  Since the rigidity of 
bone is conferred by the presence of hydroxyapatite in the osteoid matrix, this 
trend could be supported by the greater BV, TV, BMC, and mineralized tissue 
volume observed in B6.  Furthermore, the toughness (work to fracture) of B6 
callus was less than C3, which we would expect given that the CECT data 
indicated that the B6 was more highly mineralized.  Since C3 showed slower 
healing as indicated by the mRNA analysis, and thus, more compliance at day 
21, it required more energy to fracture.  In this regard, we found that BMD data 
was consistent with rigidity, as previously reported (Morgan et al., 2009).  These 
properties of B6 callus indicate that the bony callus of B6 was sufficiently larger 
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than the other two strains.  The lack of statistical significance in these parameters 
(rigidity, BV, TV, BMC, BMD, and mineralized tissue volume) between AJ and C3 
suggest that AJ and C3 develop the similar size calluses with similar structural 
properties, as all indicated measures had a power of 99% to 100%. 
Although significant correlations between biomechanical characteristics 
(i.e. strength) and tissue mineral density parameters of fracture calluses have 
been reported, we did not find such a relationship in that one could predict the 
other (Morgan et al., 2009).  While there were significant differences in mineral 
density between strains, there were no differences in callus strength, as we 
would have expected.  It is known that the relationship between biomechanical 
characteristics can be influenced by factors related to callus geometry (Sumner-
Smith & Fackelmen, 2002).  For this reason, we compared another structural 
property, effective polar moment of inertia, which describes the geometry of the 
callus, in order to help explain our findings.  This geometrical property describes 
the shape of how tissue is distributed around the bone and fracture.  From 
knowing the polar moment of inertia, a larger long bone radius can withstand a 
greater shear stress caused by torsional testing (Sumner-Smith & Fackelmen, 
2002).  Spiral fractures, which result from a twisting force, would begin in the 
region where the polar moment of inertia is the smallest.  Moreover, the purpose 
of a callus formation during fracture healing is to increase the polar moment of 
inertia so that the fracture site can have greater resistance toward a twisting 
force (Norden & Frankel, 2001).  The further away the callus material is 
 63 
distributed with respect to the central axis of loading, the higher the polar 
moment of inertia.  Therefore, a bone with a larger radius/callus has a higher 
resistance to twisting, and greater strength, than a smaller callus.   
Since we found a greater effective polar moment of inertia and 
attenuation-weighted, effective polar moment of inertia in B6 calluses, which was 
consistent with BV, TV, BMC, and mineralized tissue volume, but did not explain 
our lack of differences in strength, this led us to compare our results of strength 
at 21 days again to previously published data of unfractured femora to gain a 
sense of the regain of strength.  The strength of intact, unfractured femora have 
been reported to be 32.9 ± 6.1 Nmm for AJ, 41.0 ± 4.0 Nmm for B6, and 45.5 ± 
7.2 Nmm for C3, given as mean ± SD (Jepsen et al., 2008).  From these values 
and our values at day 21 post fracture, the regain of strength of AJ, B6, and C3 
was 92%, 70%, and 85%, respectively.  Based on these comparisons, one 
possible conclusion was that although B6 developed a larger callus, the B6 had a 
poorer bone quality within the newly developed callus that could not be 
accounted for in our comparisons.  A way to address this could be to compare 
histological sections of calluses from each strain. 
The results of the TMD from µCT and CECT showed greater diversity 
among the strains.  Tissue mineral density is defined as the mean voxel density 
measurement (mg HA/cm3) of the BV (volume of calcified bone tissue) 
segmented region of the callus.  While µCT results showed that AJ had a greater 
TMD than B6 and C3, and that C3 had a trend of greater TMD than B6, CECT 
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results showed that both AJ and B6 had a greater TMD than C3.  Prior studies 
have found C3 to have higher TMD than B6 at day 9.5 post fracture (Hayward, 
de Bakker, Gerstenfeld, Grinstaff, & Morgan, 2013) and 21 days post fracture 
(Jepsen et al., 2008), which was consistent with our µCT trend, but opposite to 
our finding from CECT.  The results of the former study corroborate our finding 
from gene analysis, in that the briefer duration of cartilage formation and 
induction of osteogenesis at an earlier time, would translate to a higher TMD at 
day 9.5.  However, a third study also conducted histomorphometric evaluations 
of fracture calluses in B6 and C3 mice and found a higher proportion of tissue 
mineralization and a larger endochondral ossification index (percent bone x 
percent cartilage) in B6 compared to C3 calluses at day 28 (Manigrasso & 
O’Connor, 2008), which agreed with our results from µCT.  A possible 
explanation for this difference was that in our µCT evaluations we included the 
whole callus, whereas in our CECT evaluations we included only included 294 
slices, or about 3528 µm (1764 µm above the fracture gap and 1764 µm below 
the fracture gap). 
Recent studies have also suggested that both strength and rigidity were 
directly related to the standard deviation in mineral density (TMD.sd) (Morgan et 
al., 2009; Weis et al., 2012).  In the present study, we were unable to corroborate 
these findings.  However, while we found no difference in TMD.sd between the 
strains, we also found no difference in strength and rigidity.  One possible 
explanation is that day 21 post fracture is an important transition between 
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endochondral and intramembranous bone formation, therefore mineralized 
cartilage and bone material exist together in the fracture callus.  The ratio of 
mineralized tissue to cartilage has been shown to affect the maximum torque that 
a bone is able to withstand (Mehta, Heyland, Toben, & Duda, 2013; Morgan et al., 
2009; Sumner-Smith & Fackelman, 2002).  Based on our µCT calculated TMD 
and CECT calculated TMD, we found variation within strains, which would affect 
this ratio.  Thus, given the strong predictive quality of TMD and TMD.sd for 
characterizing the variation of healing patterns in calluses, it may be necessary to 
increase the power of the study in order to account for such diversity.   
Some aspects of this study also require further discussion.  The strength 
of C3 calluses determined in this study at day 21 was greater than prior studies 
(Jepsen et al., 2008; Manigrasso & O’Connor, 2008).  One possible explanation 
for this was that the calluses used for mechanical testing might not have been 
fully representative of the C3 strain.  Two samples that were scanned with µCT 
were unable to be mechanically tested due to their unstable fracture calluses, 
therefore, limiting the test results to calluses with a more organized central region 
of the callus and more developed bridging callus.  The use of described µCT-
derived measures that have been shown to predict callus biomechanical 
properties (Morgan et al., 2009; Weis et al., 2012) should be investigated further 
to allow for comparisons of calluses that do not have the same stability required 
for mechanical testing. 
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In summary, the comparisons of gene expression, µCT, torsional testing, 
and CECT findings indicated that the bone development near the fracture gap of 
C3 calluses developed and mineralized at a slower rate compared to AJ and B6.  
The temporal gene profiling indicated that C3 calluses formed by way of a slower 
and less coordinated progression from cartilage development to bone 
development, lending also to slower intramembranous bone formation within the 
fracture gap.  This slower progression was also noticeable in the µCT and CECT 
3D image reconstructions.  In contrast, AJ and B6 showed faster healing than the 
C3 strain based on gene expression, torsional testing, and tissue mineralization 
analysis.  Accordingly, the variation in fracture healing rates appeared to be due 
to the differences in progression of chondrogenic and osteogenic development 
during the callus formation.  
  
Conclusion 
 Fracture healing is a complex trait in which interactions between genetic 
and environmental factors contribute to the individual phenotypic properties.  
Thus, individuals with genetically different backgrounds may cope with 
environmental perturbations differently, for example, without leading to a loss of 
function.  In addition to strain comparisons, employing different environmental 
perturbations in further studies, such as phosphate restriction to inhibit healing, 
or administration of supplemental parathyroid hormone to enhance fracture 
healing, the interactions between these factors could be utilized to further 
understand elements that regulate fracture healing.  In this way, genetic diversity 
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affecting fracture healing may be buffered by environmental perturbations, and 
when not fully compensated, bone regeneration would be expected to be altered.  
This would allow the component parts of fracture healing to be pieced apart, 
which would enable a better understanding of the underlying mechanisms 
involved. 
 From a clinical perspective, determining elements to consider in a given 
genetic background, such as the rates of development for various tissues 
(through the temporal presence of specific genes) could be predictive and/or 
indicative of diversity in the process of fracture healing, and thus be clinically 
relevant.  For instance, a better understanding of these quantitative traits could 
assist physicians in better determining when fracture patients can return to 
regular activities and resume full weight bearing.  Furthermore, identifying the 
genetic profile of fracture healing could be useful in identifying patients who might 
be at a higher risk for complications following a traumatic fracture or surgical 
tumor resection, or who might have impaired healing that could lead to 
nonunions.  Understanding the biological components of fracture healing may 
also serve as a template from which molecular response modifiers or treatments 
could be developed to alter fracture healing responses in individuals who have 
been identified to be at a higher risk for complications, such as a slower 
response to healing.  
 A better understanding of the genetic networks related to fracture healing 
could be beneficial for understanding factors that contribute to the genetic 
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variability seen in fracture healing, as well as factors that contribute to impaired 
fracture healing and nonunions.  The identification of differential gene 
expression, structural properties, and biomechanical traits observed during callus 
formation in AJ, B6, and C3 strains with well-defined variations in bone quality 
therefore could be very enlightening for the diversity likely observed in human 
fracture healing.  This study further highlighted the quantitative trait 
characteristics and genetic profiles that affect fracture healing, as well as the role 
genetics may eventually play in orthopedic medicine. 
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